{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:56:51Z","timestamp":1794023811687,"version":"4.8.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U54 AG062319 (AMN"],"award-info":[{"award-number":["U54 AG062319 (AMN"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["PI Kohrt)"],"award-info":[{"award-number":["PI Kohrt)"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Lundeman Family Center for Women's Health Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s11920-022-01372-x","type":"journal-article","created":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T04:02:32Z","timestamp":1664596952000},"page":"687-695","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Selective Serotonin Reuptake Inhibitors (SSRIs) in Pregnancy: An Updated Review on Risks to Mother, Fetus, and Child"],"prefix":"10.1007","volume":"24","author":[{"given":"Lindsay G.","family":"Lebin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Novick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,1]]},"reference":[{"issue":"5 Pt 1","key":"1372_CR1","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1097\/01.AOG.0000183597.31630.db","volume":"106","author":"NI Gavin","year":"2005","unstructured":"Gavin NI, Gaynes BN, Lohr KN, Meltzer-Brody S, Gartlehner G, Swinson T. Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol. 2005;106(5 Pt 1):1071\u201383. https:\/\/doi.org\/10.1097\/01.AOG.0000183597.31630.db.","journal-title":"Obstet Gynecol"},{"issue":"6","key":"1372_CR2","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1001\/jama.2019.0007","volume":"321","author":"UPST Force","year":"2019","unstructured":"Force UPST. Interventions to prevent perinatal depression: US Preventive Services Task Force recommendation statement. JAMA. 2019;321(6):580\u20137. https:\/\/doi.org\/10.1001\/jama.2019.0007.","journal-title":"JAMA"},{"key":"1372_CR3","doi-asserted-by":"publisher","unstructured":"Molenaar NM, Bais B, Lambregtse-van den Berg MP, Mulder CL, Howell EA, Fox NS, et al. The international prevalence of antidepressant use before, during, and after pregnancy: a systematic review and meta-analysis of timing, type of prescriptions and geographical variability. J Affect Disord. 2020;264:82\u20139. https:\/\/doi.org\/10.1016\/j.jad.2019.12.014.","DOI":"10.1016\/j.jad.2019.12.014"},{"key":"1372_CR4","doi-asserted-by":"publisher","unstructured":"Andrade SE, Reichman ME, Mott K, Pitts M, Kieswetter C, Dinatale M, et al. Use of selective serotonin reuptake inhibitors (SSRIs) in women delivering liveborn infants and other women of child-bearing age within the U.S. Food and Drug Administration\u2019s Mini-Sentinel program. Arch Women\u2019s Ment Health. 2016;19(6):969\u201377. https:\/\/doi.org\/10.1007\/s00737-016-0637-1.","DOI":"10.1007\/s00737-016-0637-1"},{"issue":"2","key":"1372_CR5","doi-asserted-by":"publisher","first-page":"194.e1","DOI":"10.1016\/j.ajog.2007.07.036","volume":"198","author":"SE Andrade","year":"2008","unstructured":"Andrade SE, Raebel MA, Brown J, Lane K, Livingston J, Boudreau D, et al. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol. 2008;198(2):194.e1-5. https:\/\/doi.org\/10.1016\/j.ajog.2007.07.036.","journal-title":"Am J Obstet Gynecol"},{"key":"1372_CR6","doi-asserted-by":"publisher","unstructured":"Ornoy A, Koren G. SSRIs and SNRIs (SRI) in pregnancy: effects on the course of pregnancy and the offspring: how far are we from having all the answers? Int J Mol Sci. 2019;20(10). https:\/\/doi.org\/10.3390\/ijms20102370.","DOI":"10.3390\/ijms20102370"},{"issue":"2","key":"1372_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/acps.12046","volume":"127","author":"A Einarson","year":"2013","unstructured":"Einarson A. The importance of critical evaluation of the literature regarding safety of antidepressant use in pregnancy. Acta Psychiatr Scand. 2013;127(2):115\u20136. https:\/\/doi.org\/10.1111\/acps.12046.","journal-title":"Acta Psychiatr Scand"},{"issue":"9","key":"1372_CR8","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/pds.3798","volume":"24","author":"SA Swanson","year":"2015","unstructured":"Swanson SA, Hernandez-Diaz S, Palmsten K, Mogun H, Olfson M, Huybrechts KF. Methodological considerations in assessing the effectiveness of antidepressant medication continuation during pregnancy using administrative data. Pharmacoepidemiol Drug Saf. 2015;24(9):934\u201342. https:\/\/doi.org\/10.1002\/pds.3798.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"1372_CR9","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/bcp.12849","volume":"81","author":"A B\u00e9rard","year":"2016","unstructured":"B\u00e9rard A, Iessa N, Chaabane S, Muanda FT, Boukhris T, Zhao JP. The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis. Br J Clin Pharmacol. 2016;81(4):589\u2013604. https:\/\/doi.org\/10.1111\/bcp.12849.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"1372_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/bdrb.20099","volume":"80","author":"A B\u00e9rard","year":"2007","unstructured":"B\u00e9rard A, Ramos E, Rey E, Blais L, St-Andr\u00e9 M, Oraichi D. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage. Birth Defects Res B Dev Reprod Toxicol. 2007;80(1):18\u201327. https:\/\/doi.org\/10.1002\/bdrb.20099.","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"issue":"5","key":"1372_CR11","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.clinthera.2007.05.003","volume":"29","author":"B Bar-Oz","year":"2007","unstructured":"Bar-Oz B, Einarson T, Einarson A, Boskovic R, O\u2019Brien L, Malm H, et al. Paroxetine and congenital malformations: meta-analysis and consideration of potential confounding factors. Clin Ther. 2007;29(5):918\u201326. https:\/\/doi.org\/10.1016\/j.clinthera.2007.05.003.","journal-title":"Clin Ther"},{"issue":"25","key":"1372_CR12","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1056\/NEJMoa1312828","volume":"370","author":"KF Huybrechts","year":"2014","unstructured":"Huybrechts KF, Palmsten K, Avorn J, Cohen LS, Holmes LB, Franklin JM, et al. Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med. 2014;370(25):2397\u2013407. https:\/\/doi.org\/10.1056\/NEJMoa1312828.","journal-title":"N Engl J Med"},{"key":"1372_CR13","doi-asserted-by":"publisher","unstructured":"Wang S, Yang L, Wang L, Gao L, Xu B, Xiong Y. Selective serotonin reuptake inhibitors (SSRIs) and the risk of congenital heart defects: a meta-analysis of prospective cohort studies. J Am Heart Assoc. 2015;4(5). https:\/\/doi.org\/10.1161\/jaha.114.001681.","DOI":"10.1161\/jaha.114.001681"},{"issue":"12","key":"1372_CR14","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1001\/jamapsychiatry.2020.2453","volume":"77","author":"KN Anderson","year":"2020","unstructured":"\u2022\u2022 Anderson KN, Lind JN, Simeone RM, Bobo WV, Mitchell AA, Riehle-Colarusso T, et al. Maternal use of specific antidepressant medications during early pregnancy and the risk of selected birth defects. JAMA Psychiat. 2020;77(12):1246\u201355. https:\/\/doi.org\/10.1001\/jamapsychiatry.2020.2453. This large case-control study demonstrates that\nassociations between individual SSRIs and congenital heart defects disappear\nafter adjusting for confounding by indication.","journal-title":"JAMA Psychiat"},{"issue":"12","key":"1372_CR15","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1001\/jamapsychiatry.2020.1512","volume":"77","author":"KL Wisner","year":"2020","unstructured":"Wisner KL, Oberlander TF, Huybrechts KF. The association between antidepressant exposure and birth defects\u2014are we there yet? JAMA Psychiat. 2020;77(12):1215\u20136. https:\/\/doi.org\/10.1001\/jamapsychiatry.2020.1512.","journal-title":"JAMA Psychiat"},{"issue":"3","key":"1372_CR16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s40264-020-01027-x","volume":"44","author":"C De Vries","year":"2021","unstructured":"De Vries C, Gadzhanova S, Sykes MJ, Ward M, Roughead E. A systematic review and meta-analysis considering the risk for congenital heart defects of antidepressant classes and individual antidepressants. Drug Saf. 2021;44(3):291\u2013312. https:\/\/doi.org\/10.1007\/s40264-020-01027-x.","journal-title":"Drug Saf"},{"key":"1372_CR17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jpsychires.2020.02.023","volume":"124","author":"A Biffi","year":"2020","unstructured":"Biffi A, Cantarutti A, Rea F, Locatelli A, Zanini R, Corrao G. Use of antidepressants during pregnancy and neonatal outcomes: an umbrella review of meta-analyses of observational studies. J Psychiatr Res. 2020;124:99\u2013108. https:\/\/doi.org\/10.1016\/j.jpsychires.2020.02.023.","journal-title":"J Psychiatr Res"},{"issue":"1","key":"1372_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/pd.5846","volume":"41","author":"SJ Melov","year":"2021","unstructured":"Melov SJ, Shetty PS, Pasupathy D, Kirby A, Sholler GF, Winlaw DS, et al. Selective serotonin reuptake inhibitor or serotonin-norepinephrine reuptake inhibitors and epidemiological characteristics associated with prenatal diagnosis of congenital heart disease. Prenat Diagn. 2021;41(1):35\u201342. https:\/\/doi.org\/10.1002\/pd.5846.","journal-title":"Prenat Diagn"},{"issue":"1","key":"1372_CR19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/s1701-2163(15)30364-9","volume":"37","author":"Y Gadot","year":"2015","unstructured":"Gadot Y, Koren G. The use of antidepressants in pregnancy: focus on maternal risks. J Obstet Gynaecol Can. 2015;37(1):56\u201363. https:\/\/doi.org\/10.1016\/s1701-2163(15)30364-9.","journal-title":"J Obstet Gynaecol Can"},{"issue":"3","key":"1372_CR20","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1176\/appi.ajp.2008.08060817","volume":"166","author":"S Toh","year":"2009","unstructured":"Toh S, Mitchell AA, Louik C, Werler MM, Chambers CD, Hern\u00e1ndez-D\u00edaz S. Selective serotonin reuptake inhibitor use and risk of gestational hypertension. Am J Psychiatry. 2009;166(3):320\u20138. https:\/\/doi.org\/10.1176\/appi.ajp.2008.08060817.","journal-title":"Am J Psychiatry"},{"issue":"10","key":"1372_CR21","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1017\/s0033291709992194","volume":"40","author":"M Reis","year":"2010","unstructured":"Reis M, K\u00e4ll\u00e9n B. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med. 2010;40(10):1723\u201333. https:\/\/doi.org\/10.1017\/s0033291709992194.","journal-title":"Psychol Med"},{"key":"1372_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f4877","volume":"347","author":"K Palmsten","year":"2013","unstructured":"Palmsten K, Hern\u00e1ndez-D\u00edaz S, Huybrechts KF, Williams PL, Michels KB, Achtyes ED, et al. Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States. BMJ. 2013;347: f4877. https:\/\/doi.org\/10.1136\/bmj.f4877.","journal-title":"BMJ"},{"key":"1372_CR23","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jpsychires.2016.09.001","volume":"83","author":"HY Jiang","year":"2016","unstructured":"Jiang HY, Xu LL, Li YC, Deng M, Peng CT, Ruan B. Antidepressant use during pregnancy and risk of postpartum hemorrhage: a systematic review and meta-analysis. J Psychiatr Res. 2016;83:160\u20137. https:\/\/doi.org\/10.1016\/j.jpsychires.2016.09.001.","journal-title":"J Psychiatr Res"},{"issue":"1","key":"1372_CR24","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/jcp.0000000000000036","volume":"34","author":"A Lupattelli","year":"2014","unstructured":"Lupattelli A, Spigset O, Koren G, Nordeng H. Risk of vaginal bleeding and postpartum hemorrhage after use of antidepressants in pregnancy: a study from the Norwegian Mother and Child Cohort Study. J Clin Psychopharmacol. 2014;34(1):143\u20138. https:\/\/doi.org\/10.1097\/jcp.0000000000000036.","journal-title":"J Clin Psychopharmacol"},{"issue":"5","key":"1372_CR25","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1097\/EDE.0b013e31829e0aaa","volume":"24","author":"K Palmsten","year":"2013","unstructured":"Palmsten K, Huybrechts KF, Michels KB, Williams PL, Mogun H, Setoguchi S, et al. Antidepressant use and risk for preeclampsia. Epidemiology. 2013;24(5):682\u201391. https:\/\/doi.org\/10.1097\/EDE.0b013e31829e0aaa.","journal-title":"Epidemiology"},{"key":"1372_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1472-6874-7-15","volume":"7","author":"C Qiu","year":"2007","unstructured":"Qiu C, Sanchez SE, Lam N, Garcia P, Williams MA. Associations of depression and depressive symptoms with preeclampsia: results from a Peruvian case-control study. BMC Womens Health. 2007;7:15. https:\/\/doi.org\/10.1186\/1472-6874-7-15.","journal-title":"BMC Womens Health"},{"issue":"4","key":"1372_CR27","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/s0029-7844(99)00602-x","volume":"95","author":"T Kurki","year":"2000","unstructured":"Kurki T, Hiilesmaa V, Raitasalo R, Mattila H, Ylikorkala O. Depression and anxiety in early pregnancy and risk for preeclampsia. Obstet Gynecol. 2000;95(4):487\u201390. https:\/\/doi.org\/10.1016\/s0029-7844(99)00602-x.","journal-title":"Obstet Gynecol"},{"key":"1372_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.phrs.2016.08.017","volume":"118","author":"S Laporte","year":"2017","unstructured":"Laporte S, Chapelle C, Caillet P, Beyens MN, Bellet F, Delavenne X, et al. Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: a meta-analysis of observational studies. Pharmacol Res. 2017;118:19\u201332. https:\/\/doi.org\/10.1016\/j.phrs.2016.08.017.","journal-title":"Pharmacol Res"},{"issue":"7516","key":"1372_CR29","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1136\/bmj.331.7516.529","volume":"331","author":"C Paton","year":"2005","unstructured":"Paton C, Ferrier IN. SSRIs and gastrointestinal bleeding. BMJ. 2005;331(7516):529\u201330. https:\/\/doi.org\/10.1136\/bmj.331.7516.529.","journal-title":"BMJ"},{"issue":"11","key":"1372_CR30","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1111\/1471-0528.16210","volume":"127","author":"A Skalkidou","year":"2020","unstructured":"Skalkidou A, Sundstr\u00f6m-Poromaa I, Wikman A, Hesselman S, Wikstr\u00f6m AK, Elenis E. SSRI use during pregnancy and risk for postpartum haemorrhage: a national register-based cohort study in Sweden. BJOG. 2020;127(11):1366\u201373. https:\/\/doi.org\/10.1111\/1471-0528.16210.","journal-title":"BJOG"},{"issue":"5","key":"1372_CR31","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/ppe.12660","volume":"34","author":"K Palmsten","year":"2020","unstructured":"\u2022\u2022 Palmsten K, Chambers CD, Wells A, Bandoli G. Patterns of prenatal antidepressant exposure and risk of preeclampsia and postpartum haemorrhage. Paediatr Perinat Epidemiol. 2020;34(5):597\u2013606. https:\/\/doi.org\/10.1111\/ppe.12660. This health claims data study describes a\ndose-dependent increase in risk of pre-eclampsia and postpartum hemorrhage with\nperinatal SSRI exposure.","journal-title":"Paediatr Perinat Epidemiol"},{"key":"1372_CR32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jpsychires.2015.11.005","volume":"73","author":"DR Kim","year":"2016","unstructured":"Kim DR, Pinheiro E, Luther JF, Eng HF, Dills JL, Wisniewski SR, et al. Is third trimester serotonin reuptake inhibitor use associated with postpartum hemorrhage? J Psychiatr Res. 2016;73:79\u201385. https:\/\/doi.org\/10.1016\/j.jpsychires.2015.11.005.","journal-title":"J Psychiatr Res"},{"issue":"2","key":"1372_CR33","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1177\/1060028018794005","volume":"53","author":"AL Bixby","year":"2018","unstructured":"Bixby AL, VandenBerg A, Bostwick JR. Clinical management of bleeding risk with antidepressants. Ann Pharmacother. 2018;53(2):186\u201394. https:\/\/doi.org\/10.1177\/1060028018794005.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"1372_CR34","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12884-017-1334-4","volume":"17","author":"HM Heller","year":"2017","unstructured":"Heller HM, Ravelli ACJ, Bruning AHL, de Groot CJM, Scheele F, van Pampus MG, et al. Increased postpartum haemorrhage, the possible relation with serotonergic and other psychopharmacological drugs: a matched cohort study. BMC Pregnancy Childbirth. 2017;17(1):166. https:\/\/doi.org\/10.1186\/s12884-017-1334-4.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"1372_CR35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/s0301-2115(00)00367-5","volume":"95","author":"AC Bolte","year":"2001","unstructured":"Bolte AC, van Geijn HP, Dekker GA. Pathophysiology of preeclampsia and the role of serotonin. Eur J Obstet Gynecol Reprod Biol. 2001;95(1):12\u201321. https:\/\/doi.org\/10.1016\/s0301-2115(00)00367-5.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"12","key":"1372_CR36","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1002\/1529-0131(199912)42:12<2561::Aid-anr8>3.0.Co;2-u","volume":"42","author":"I Yaron","year":"1999","unstructured":"Yaron I, Shirazi I, Judovich R, Levartovsky D, Caspi D, Yaron M. Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic acid production in human synovial cells and synovial tissue cultures. Arthritis Rheum. 1999;42(12):2561\u20138. https:\/\/doi.org\/10.1002\/1529-0131(199912)42:12%3c2561::Aid-anr8%3e3.0.Co;2-u.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1372_CR37","first-page":"653","volume":"32","author":"MS Finkel","year":"1996","unstructured":"Finkel MS, Laghrissi-Thode F, Pollock BG, Rong J. Paroxetine is a novel nitric oxide synthase inhibitor. Psychopharmacol Bull. 1996;32(4):653\u20138.","journal-title":"Psychopharmacol Bull"},{"issue":"7","key":"1372_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182088","volume":"12","author":"V Salvi","year":"2017","unstructured":"Salvi V, Grua I, Cerveri G, Mencacci C, Barone-Adesi F. The risk of new-onset diabetes in antidepressant users - a systematic review and meta-analysis. PLoS ONE. 2017;12(7): e0182088. https:\/\/doi.org\/10.1371\/journal.pone.0182088.","journal-title":"PLoS ONE"},{"issue":"4","key":"1372_CR39","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.ajog.2006.02.019","volume":"194","author":"SW Wen","year":"2006","unstructured":"Wen SW, Yang Q, Garner P, Fraser W, Olatunbosun O, Nimrod C, et al. Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. Am J Obstet Gynecol. 2006;194(4):961\u20136. https:\/\/doi.org\/10.1016\/j.ajog.2006.02.019.","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"1372_CR40","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-025908","volume":"9","author":"M Dandjinou","year":"2019","unstructured":"Dandjinou M, Sheehy O, B\u00e9rard A. Antidepressant use during pregnancy and the risk of gestational diabetes mellitus: a nested case-control study. BMJ Open. 2019;9(9): e025908. https:\/\/doi.org\/10.1136\/bmjopen-2018-025908.","journal-title":"BMJ Open"},{"issue":"9","key":"1372_CR41","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/pds.4799","volume":"28","author":"PD Wartko","year":"2019","unstructured":"Wartko PD, Weiss NS, Enquobahrie DA, Chan KCG, Stephenson-Famy A, Mueller BA, et al. Antidepressant continuation in pregnancy and risk of gestational diabetes. Pharmacoepidemiol Drug Saf. 2019;28(9):1194\u2013203. https:\/\/doi.org\/10.1002\/pds.4799.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"1372_CR42","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/pds.5388","volume":"31","author":"A Lupattelli","year":"2022","unstructured":"\u2022 Lupattelli A, Barone-Adesi F, Nordeng H. Association between antidepressant use in pregnancy and gestational diabetes mellitus: results from the Norwegian Mother, Father and Child Cohort Study. Pharmacoepidemiol Drug Saf. 2022;31(2):247\u201356. https:\/\/doi.org\/10.1002\/pds.5388. This study indicates that perinatal exposure to antidepressants with low H1-receptor affinity, which includes all SSRIs, does not increase risk of gestational diabetes.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"1372_CR43","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/bdra.20773","volume":"91","author":"L Colvin","year":"2011","unstructured":"Colvin L, Slack-Smith L, Stanley FJ, Bower C. Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy. Birth Defects Res A. 2011;91(3):142\u201352. https:\/\/doi.org\/10.1002\/bdra.20773.","journal-title":"Birth Defects Res A"},{"issue":"7","key":"1372_CR44","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1001\/archgenpsychiatry.2011.2333","volume":"69","author":"H El Marroun","year":"2012","unstructured":"El Marroun H, Jaddoe VWV, Hudziak JJ, Roza SJ, Steegers EAP, Hofman A, et al. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. Arch Gen Psychiatry. 2012;69(7):706\u201314. https:\/\/doi.org\/10.1001\/archgenpsychiatry.2011.2333.","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"1372_CR45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.genhosppsych.2013.08.002","volume":"36","author":"H Huang","year":"2014","unstructured":"Huang H, Coleman S, Bridge JA, Yonkers K, Katon W. A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight. Gen Hosp Psychiatry. 2014;36(1):13\u20138. https:\/\/doi.org\/10.1016\/j.genhosppsych.2013.08.002.","journal-title":"Gen Hosp Psychiatry"},{"issue":"19","key":"1372_CR46","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1001\/jama.293.19.2372","volume":"293","author":"EL Moses-Kolko","year":"2005","unstructured":"Moses-Kolko EL, Bogen D, Perel J, Bregar A, Uhl K, Levin B, et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors literature review and implications for clinical applications. JAMA. 2005;293(19):2372\u201383. https:\/\/doi.org\/10.1001\/jama.293.19.2372.","journal-title":"JAMA"},{"issue":"6","key":"1372_CR47","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1056\/NEJMoa052744","volume":"354","author":"CD Chambers","year":"2006","unstructured":"Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med. 2006;354(6):579\u201387. https:\/\/doi.org\/10.1056\/NEJMoa052744.","journal-title":"N Engl J Med"},{"issue":"4","key":"1372_CR48","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1001\/jamapsychiatry.2013.684","volume":"70","author":"LE Ross","year":"2013","unstructured":"Ross LE, Grigoriadis S, Mamisashvili L, VonderPorten EH, Roerecke M, Rehm J, et al. Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. JAMA Psychiat. 2013;70(4):436\u201343. https:\/\/doi.org\/10.1001\/jamapsychiatry.2013.684.","journal-title":"JAMA Psychiat"},{"issue":"21","key":"1372_CR49","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1001\/jama.2015.5605","volume":"313","author":"KF Huybrechts","year":"2015","unstructured":"Huybrechts KF, Bateman BT, Palmsten K, Desai RJ, Patorno E, Gopalakrishnan C, et al. Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn. JAMA. 2015;313(21):2142\u201351. https:\/\/doi.org\/10.1001\/jama.2015.5605.","journal-title":"JAMA"},{"issue":"1","key":"1372_CR50","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/acps.13120","volume":"141","author":"CA Fitton","year":"2020","unstructured":"Fitton CA, Steiner MFC, Aucott L, Pell JP, Mackay DF, Fleming M, et al. In utero exposure to antidepressant medication and neonatal and child outcomes: a systematic review. Acta Psychiatr Scand. 2020;141(1):21\u201333. https:\/\/doi.org\/10.1111\/acps.13120.","journal-title":"Acta Psychiatr Scand"},{"key":"1372_CR51","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ejogrb.2020.11.062","volume":"257","author":"E Wolgast","year":"2021","unstructured":"Wolgast E, Lilliecreutz C, Sydsj\u00f6 G, Bladh M, Josefsson A. The impact of major depressive disorder and antidepressant medication before and during pregnancy on obstetric and neonatal outcomes: a nationwide population-based study. Eur J Obstet Gynecol Reprod Biol. 2021;257:42\u201350. https:\/\/doi.org\/10.1016\/j.ejogrb.2020.11.062.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"1372_CR52","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1097\/aog.0000000000004538","volume":"138","author":"R Vlenterie","year":"2021","unstructured":"Vlenterie R, van Gelder M, Anderson HR, Andersson L, Broekman BFP, Dubnov-Raz G, et al. Associations between maternal depression, antidepressant use during pregnancy, and adverse pregnancy outcomes: an individual participant data meta-analysis. Obstet Gynecol. 2021;138(4):633\u201346. https:\/\/doi.org\/10.1097\/aog.0000000000004538.","journal-title":"Obstet Gynecol"},{"key":"1372_CR53","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d8012","volume":"344","author":"H Kieler","year":"2012","unstructured":"Kieler H, Artama M, Engeland A, Ericsson \u00d6, Furu K, Gissler M, et al. Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries. BMJ. 2012;344: d8012. https:\/\/doi.org\/10.1136\/bmj.d8012.","journal-title":"BMJ"},{"key":"1372_CR54","doi-asserted-by":"publisher","unstructured":"\u2022 Masarwa R, Bar-Oz B, Gorelik E, Reif S, Perlman A, Matok I. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis. Am J Obstet Gynecol. 2019;220(1):57.e1-.e13. https:\/\/doi.org\/10.1016\/j.ajog.2018.08.030. This network meta-analysis demonstrates that perinatal SSRI exposure is associated with low absolute risk of persistent pulmonary hypertension of the newborn, with sertraline having lowest risk compared to other antidepressants.","DOI":"10.1016\/j.ajog.2018.08.030"},{"issue":"3","key":"1372_CR55","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1089\/jwh.2018.7319","volume":"28","author":"QX Ng","year":"2019","unstructured":"Ng QX, Venkatanarayanan N, Ho CYX, Sim WS, Lim DY, Yeo WS. Selective serotonin reuptake inhibitors and persistent pulmonary hypertension of the newborn: an update meta-analysis. J Womens Health (Larchmt). 2019;28(3):331\u20138. https:\/\/doi.org\/10.1089\/jwh.2018.7319.","journal-title":"J Womens Health (Larchmt)"},{"issue":"12","key":"1372_CR56","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/nrn1256","volume":"4","author":"P Gaspar","year":"2003","unstructured":"Gaspar P, Cases O, Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci. 2003;4(12):1002\u201312. https:\/\/doi.org\/10.1038\/nrn1256.","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"1372_CR57","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/jcpp.13004","volume":"60","author":"AC Sujan","year":"2019","unstructured":"Sujan AC, \u00d6berg AS, Quinn PD, D\u2019Onofrio BM. Annual research review: maternal antidepressant use during pregnancy and offspring neurodevelopmental problems - a critical review and recommendations for future research. J Child Psychol Psychiatry. 2019;60(4):356\u201376. https:\/\/doi.org\/10.1111\/jcpp.13004.","journal-title":"J Child Psychol Psychiatry"},{"issue":"12","key":"1372_CR58","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1111\/1471-0528.13611","volume":"123","author":"LE Grzeskowiak","year":"2016","unstructured":"Grzeskowiak LE, Morrison JL, Henriksen TB, Bech BH, Obel C, Olsen J, et al. Prenatal antidepressant exposure and child behavioural outcomes at 7 years of age: a study within the Danish National Birth Cohort. BJOG. 2016;123(12):1919\u201328. https:\/\/doi.org\/10.1111\/1471-0528.13611.","journal-title":"BJOG"},{"issue":"5","key":"1372_CR59","doi-asserted-by":"publisher","first-page":"e1241","DOI":"10.1542\/peds.2013-3406","volume":"133","author":"RA Harrington","year":"2014","unstructured":"Harrington RA, Lee LC, Crum RM, Zimmerman AW, Hertz-Picciotto I. Prenatal SSRI use and offspring with autism spectrum disorder or developmental delay. Pediatrics. 2014;133(5):e1241\u20138. https:\/\/doi.org\/10.1542\/peds.2013-3406.","journal-title":"Pediatrics"},{"issue":"10","key":"1372_CR60","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.4088\/JCP.13m08902","volume":"75","author":"AK Santucci","year":"2014","unstructured":"Santucci AK, Singer LT, Wisniewski SR, Luther JF, Eng HF, Dills JL, et al. Impact of prenatal exposure to serotonin reuptake inhibitors or maternal major depressive disorder on infant developmental outcomes. J Clin Psychiatry. 2014;75(10):1088\u201395. https:\/\/doi.org\/10.4088\/JCP.13m08902.","journal-title":"J Clin Psychiatry"},{"issue":"9956","key":"1372_CR61","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1016\/S0140-6736(14)61277-0","volume":"384","author":"A Stein","year":"2014","unstructured":"Stein A, Pearson RM, Goodman SH, Rapa E, Rahman A, McCallum M, et al. Effects of perinatal mental disorders on the fetus and child. The Lancet. 2014;384(9956):1800\u201319. https:\/\/doi.org\/10.1016\/S0140-6736(14)61277-0.","journal-title":"The Lancet"},{"issue":"12","key":"1372_CR62","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1001\/jamapsychiatry.2019.2859","volume":"76","author":"E Dragioti","year":"2019","unstructured":"\u2022\u2022 Dragioti E, Solmi M, Favaro A, Fusar-Poli P, Dazzan P, Thompson T, et al. Association of antidepressant use with adverse health outcomes: a systematic umbrella review. JAMA Psychiat. 2019;76(12):1241\u201355. https:\/\/doi.org\/10.1001\/jamapsychiatry.2019.2859. This umbrella review of 45 meta-analyses suggests that the association between perinatal SSRI use and autism spectrum disorder studies attenuates after adjustment for confounding by indication.","journal-title":"JAMA Psychiat"},{"issue":"4","key":"1372_CR63","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.biopsych.2021.04.002","volume":"90","author":"JL Ames","year":"2021","unstructured":"\u2022 Ames JL, Ladd-Acosta C, Fallin MD, Qian Y, Schieve LA, DiGuiseppi C, et al. Maternal psychiatric conditions, treatment with selective serotonin reuptake inhibitors, and neurodevelopmental disorders. Biol Psychiatry. 2021;90(4):253\u201362. https:\/\/doi.org\/10.1016\/j.biopsych.2021.04.002. This case-control study indicates that maternal psychiatric illness and not SSRI exposure significantly increases risk of neurodevelopmental disorders in offspring.","journal-title":"Biol Psychiatry"},{"key":"1372_CR64","doi-asserted-by":"publisher","unstructured":"\u2022 Rommel AS, Bergink V, Liu X, Munk-Olsen T, Molenaar NM. Long-term effects of intrauterine exposure to antidepressants on physical, neurodevelopmental, and psychiatric outcomes: a systematic review. J Clin Psychiatry. 2020;81(3). https:\/\/doi.org\/10.4088\/JCP.19r12965. A systematic meta-analysis of 34 studies shows no impact of antidepressant exposure on neurodevelopmental outcomes including cognition, behavior, IQ, motor development, speech, language, and scholastic outcomes, though does suggest increased risk of affective disorders in offspring.","DOI":"10.4088\/JCP.19r12965"},{"issue":"12","key":"1372_CR65","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1111\/1471-0528.16743","volume":"128","author":"A Lupattelli","year":"2021","unstructured":"Lupattelli A, Mahic M, Handal M, Ystrom E, Reichborn-Kjennerud T, Nordeng H. Attention-deficit\/hyperactivity disorder in children following prenatal exposure to antidepressants: results from the Norwegian mother, father and child cohort study. BJOG. 2021;128(12):1917\u201327. https:\/\/doi.org\/10.1111\/1471-0528.16743.","journal-title":"BJOG"},{"key":"1372_CR66","doi-asserted-by":"publisher","unstructured":"\u2022 Singal D, Chateau D, Struck S, Lee JB, Dahl M, Derksen S, et al. In utero antidepressants and neurodevelopmental outcomes in kindergarteners. Pediatrics. 2020;145(5). https:\/\/doi.org\/10.1542\/peds.2019-1157. This retrospective cohort study examines neurodevelopmental outcomes in school-aged children perinatal SSRI\/SNRI exposure and suggests increased risk of developmental vulnerability in antidepressant-exposed children.","DOI":"10.1542\/peds.2019-1157"},{"issue":"17","key":"1372_CR67","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1001\/jama.2021.17380","volume":"326","author":"J Christensen","year":"2021","unstructured":"\u2022 Christensen J, Trabjerg BB, Sun Y, Dreier JW. Association of maternal antidepressant prescription during pregnancy with standardized test scores of Danish school-aged children. JAMA. 2021;326(17):1725\u201335. https:\/\/doi.org\/10.1001\/jama.2021.17380. This retrospective cohort study examines cognitive outcomes in children exposed to SSRIs in utero. Exposed children had a statistically significant lower score by 2 points in mathematics compared to unexposed children, though the clinical relevance of this is thought to be small. There was no difference between the groups\u2019 language scores.","journal-title":"JAMA"},{"issue":"6","key":"1372_CR68","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/mp.2014.90","volume":"20","author":"CC Clements","year":"2015","unstructured":"Clements CC, Castro VM, Blumenthal SR, Rosenfield HR, Murphy SN, Fava M, et al. Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system. Mol Psychiatry. 2015;20(6):727\u201334. https:\/\/doi.org\/10.1038\/mp.2014.90.","journal-title":"Mol Psychiatry"},{"issue":"25","key":"1372_CR69","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1056\/NEJMoa1301449","volume":"369","author":"A Hviid","year":"2013","unstructured":"Hviid A, Melbye M, Pasternak B. Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism. N Engl J Med. 2013;369(25):2406\u201315. https:\/\/doi.org\/10.1056\/NEJMoa1301449.","journal-title":"N Engl J Med"},{"issue":"5","key":"1372_CR70","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jaac.2016.02.013","volume":"55","author":"H Malm","year":"2016","unstructured":"Malm H, Brown AS, Gissler M, Gyllenberg D, Hinkka-Yli-Salom\u00e4ki S, McKeague IW, et al. Gestational exposure to selective serotonin reuptake inhibitors and offspring psychiatric disorders: a national register-based study. J Am Acad Child Adolesc Psychiatry. 2016;55(5):359\u201366. https:\/\/doi.org\/10.1016\/j.jaac.2016.02.013.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"15","key":"1372_CR71","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1001\/jama.2017.3415","volume":"317","author":"HK Brown","year":"2017","unstructured":"Brown HK, Ray JG, Wilton AS, Lunsky Y, Gomes T, Vigod SN. Association between serotonergic antidepressant use during pregnancy and autism spectrum disorder in children. JAMA. 2017;317(15):1544\u201352. https:\/\/doi.org\/10.1001\/jama.2017.3415.","journal-title":"JAMA"},{"issue":"15","key":"1372_CR72","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1001\/jama.2017.3413","volume":"317","author":"AC Sujan","year":"2017","unstructured":"Sujan AC, Rickert ME, Oberg AS, Quinn PD, Hernandez-Diaz S, Almqvist C, et al. Associations of maternal antidepressant use during the first trimester of pregnancy with preterm birth, small for gestational age, autism spectrum disorder, and attention-deficit\/hyperactivity disorder in offspring. JAMA. 2017;317(15):1553\u201362. https:\/\/doi.org\/10.1001\/jama.2017.3413.","journal-title":"JAMA"},{"issue":"8","key":"1372_CR73","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1001\/archgenpsychiatry.2010.86","volume":"67","author":"K Dean","year":"2010","unstructured":"Dean K, Stevens H, Mortensen PB, Murray RM, Walsh E, Pedersen CB. Full spectrum of psychiatric outcomes among offspring with parental history of mental disorder. Arch Gen Psychiatry. 2010;67(8):822\u20139. https:\/\/doi.org\/10.1001\/archgenpsychiatry.2010.86.","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"1372_CR74","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s10578-012-0291-4","volume":"43","author":"D Kingston","year":"2012","unstructured":"Kingston D, Tough S, Whitfield H. Prenatal and postpartum maternal psychological distress and infant development: a systematic review. Child Psychiatry Hum Dev. 2012;43(5):683\u2013714. https:\/\/doi.org\/10.1007\/s10578-012-0291-4.","journal-title":"Child Psychiatry Hum Dev"},{"key":"1372_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2020.112769","volume":"284","author":"A Oyetunji","year":"2020","unstructured":"Oyetunji A, Chandra P. Postpartum stress and infant outcome: a review of current literature. Psychiatry Res. 2020;284: 112769. https:\/\/doi.org\/10.1016\/j.psychres.2020.112769.","journal-title":"Psychiatry Res"},{"key":"1372_CR76","doi-asserted-by":"publisher","first-page":"174550651984404","DOI":"10.1177\/1745506519844044","volume":"15","author":"J Slomian","year":"2019","unstructured":"Slomian J, Honvo G, Emonts P, Reginster JY, Bruy\u00e8re O. Consequences of maternal postpartum depression: a systematic review of maternal and infant outcomes. Womens Health (Lond). 2019;15:1745506519844044. https:\/\/doi.org\/10.1177\/1745506519844044.","journal-title":"Womens Health (Lond)"},{"key":"1372_CR77","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-3-319-92919-4_5","volume-title":"Perinatal psychopharmacology","author":"S Grigoriadis","year":"2019","unstructured":"Grigoriadis S, Peer M. Antidepressants in pregnancy. In: Uguz F, Orsolini L, editors. Perinatal psychopharmacology. Cham: Springer International Publishing; 2019;69\u201398."},{"key":"1372_CR78","unstructured":"Hunter LA, Catapano LA, Nagle-Yang SM, Williams KE, Osborne LM. Textbook of women\u2019s reproductive mental health. Textbook of reproductive psychiatry. Am Psychiatr Pub. 2021."}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-022-01372-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11920-022-01372-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-022-01372-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T01:22:21Z","timestamp":1667438541000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11920-022-01372-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,1]]},"references-count":78,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1372"],"URL":"https:\/\/doi.org\/10.1007\/s11920-022-01372-x","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"value":"1523-3812","type":"print"},{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,1]]},"assertion":[{"value":"6 September 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}